Duplex-guided Percutaneous Transluminal Angioplasty in Iliac Arterial Occlusive Disease  by Krasznai, A.G. et al.
Duplex-guided Percutaneous Transluminal Angioplasty in Iliac Arterial
Occlusive Disease
A.G. Krasznai a,y, T.A. Sigterman a,y,*, R.J. Welten a, R. Heijboer b, C.J.J.M. Sikkink a, L.H.J.M. van de Akker a, L.H. Bouwman a
a Department of Surgery, Division of Vascular Surgery, Atrium Medical Centre, Heerlen, The Netherlands
b Department of Radiology, Atrium Medical Centre, Heerlen, The Netherlandsy The
ﬁrst au
* Co
Dunant
E-ma
1078
Surgery
http:WHAT THIS PAPER ADDS
Chronic renal insufﬁciency (CRI) is a growing mondial problem with a prevalence as high as 16%. Exposure to
nephrotoxic agents can lead to contrast-induced nephropathy (CIN) in 50% of CRI patients undergoing percu-
taneous transluminal angioplasty (PTA). PTA can be performed without nephrotoxic contrast, utilizing Doppler-
ultrasound (Duplex) guidance. In our study we evaluate the safety and efﬁcacy of duplex-guided percutaneous
transluminal angioplasty in 31 patients. Duplex-guided PTA has previously been described in femoral and
popliteal lesions. As the iliac anatomy is somewhat more challenging, only one case report has been written with
regards to stenotic iliac pathology. We consider this new method to be of general interest to any vascular
surgeon and interventional radiologist.Background: Chronic renal insufﬁciency (CRI) is a growing global problem. PTA can be performed without
nephrotoxic contrast, utilizing Doppler-ultrasound (Duplex) guidance.
Duplex-guided infra-inguinal interventions and access-related interventions have been reported. Duplex-guided
iliac interventions have not been performed to any extent because of the anatomic location. In our study we
evaluated the safety and efﬁcacy of Duplex-guided percutaneous transluminal angioplasty (DuPTA) in iliac
arteries.
Methods: From June 2012 until February 2013, 31 patients (35 iliac lesions), underwent DuPTA. Indications
ranged from Rutherford 3 to 5. Preoperative evaluation included Ankle Brachial Index (ABI), Duplex and MRA.
Procedural success was deﬁned as crossing the lesion with a guidewire and dilating or stenting the lesion. Clinical
success was deﬁned as 50% reduction in peak systolic velocity (PSV) or clinical improvement. PSV was evaluated
after PTA, then at 2 weeks. Clinical results were assessed 2 weeks after the procedure.
Results: Procedural success was achieved in 94% of patients (33/35), all of whom also had clinical success. Post-
procedural PSV reduction showed an average improvement of 63% (431 cm/s to 153 cm/s). Mean preoperative
ABI was 0.72 and improved to 0.88 postoperatively.
Conclusions: PTA using Duplex-guidance in signiﬁcant iliac stenosis is a safe method with major advantages in
patients at high risk for developing contrast-induced nephropathy.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Doppler-ultrasound (Duplex) is one of the major diagnostic
tools in vascular surgery. Using Duplex, reliable measure-
ments of stenosis can be provided. Some studies show good
results treating patients endovascular with infra-inguinal
stenotic lesions utilizing Duplex-guidance.1e8 Infra-inguinalse authors contributed equally and should be recognised as joint
thors.
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//dx.doi.org/10.1016/j.ejvs.2013.08.011stenotic lesions can easily be visualized because of the
anatomical location. In 2010, Kawarada9 reported two cases
of Duplex-guidance percutaneous transluminal angioplasty
(PTA) in the iliac arteries. As no nephrotoxic contrast is
used, Duplex-guided PTA (DuPTA) is especially favourable in
patients with chronic renal insufﬁciency at high risk for
developing contrast-induced nephropathy (CIN).
Chronic renal insufﬁciency (CRI) is a global health prob-
lem, involving 10e16% of the general adult population.10
CRI patients have an increased risk for developing CIN af-
ter exposure to nephrotoxic agents. The incidence of CIN is
highly dependent on the clinical characteristics of the pa-
tient population, with an incidence of 50% or more in high-
risk patients.11
Prevention of CIN can ultimately be accomplished by
restricting the use of nephrotoxic contrast agents. The use
584 A.G. Krasznai et al.of contrast is abolished in Duplex-guided PTA. Additional
advantages are that patients and medical staff are not
exposed to radiation.
This feasibility study evaluates the safety and efﬁcacy of
DuPTA in the iliac arteries.
METHODS
From June 1, 2012 until February 1, 2013, 31 patients (25men
[71%]) were treated for 35 signiﬁcant iliac lesions in a large
teaching hospital in the south of the Netherlands, the Atrium
Medical Centre Parkstad. Inclusion criteria were chronic renal
insufﬁciency (eGFR <60 ml/min/1.73 m2) or allergy for
contrast media. Exclusion criteria were difﬁculties in visual-
izing lesions with Duplex. All patients meeting the criteria
with an indication for iliac PTA in the period of this studywere
screened for a possible DuPTA. Three-hundred conventional
iliac PTAs are performed annually (2012) in our centre. The
reported experience represents approximately 10% of all iliac
PTAs performed. All patients meeting inclusion criteria were
briefed extensively and given the choice of conventional PTA
or DuPTA. Patients were seen in the outpatient clinic and
presented with symptoms of peripheral artery disease (PAD)
with Rutherford classiﬁcation from 3 (N¼ 27, 87%), 4 (N¼ 3,
10%), and 5 (N¼ 1, 3%). TASCII A (N¼ 22), B (N¼ 11), and C
(N ¼ 2) lesions were treated.
Preoperatively all patients underwent Ankle Brachial In-
dex (ABI), Duplex arterial mapping and magnetic resonance
imaging (MRI) of the arterial vessels. A Duplex was per-
formed to determine whether these lesions would be
feasible for Duplex-guided endovascular treatment. All pa-
tients were evaluated in a multi-disciplinary setting
(vascular surgeons, interventional radiologist, and vascular
technicians). Signiﬁcant stenosis was deﬁned as more than
70% diameter reduction or more on MRA and a PSV ratio
reduction of 2 or more as shown by Duplex.Figure 1. (A) Stenosis common iliac artery as depicted by ultra-
sound in B-mode; (B) stenosis common iliac artery as depicted by
ultrasound in colour mode.Technique
All procedures were performed in the operating room (OR)
under spinal anaesthesia or short general anaesthesia (based
on request of the patient or the use of anticoagulation
therapy). Patients were examined by Duplex in the OR, prior
to performing anaesthesia conﬁrming preoperative Duplex
ﬁndings. All procedures were performed using latest gener-
ation Colour Duplex sonography (Aloka ProsoundAlfa7, Aloka
Co., Ltd., Tokyo, Japan) with a linear 3.5 MHz probe for iliac
PTA. Duplex examination was performed by experienced
vascular technologist. The vascular surgeon and vascular
technologist took place at opposite sides of the patient.
The linear probe was inserted in a sterile plastic cover
with covering gel. The common femoral artery (CFA) was
punctured by the surgeon in a retrograde fashion under
ultrasound control (5 MHz linear probe). In all cases an
uncalciﬁed segment of the artery was punctured without
complications. An 11 cm, 6 Fr Brite Tip introducer sheath
(Cordis, Cordis Congregation, FL, USA) was inserted under
Duplex control (guiding the sheath into the external iliac
artery). Heparin 2500 U was administered intravenously toall patients. A Terumo Standard 180 cm, 0.035 guidewire
(Terumo, Terumo Europe N.V., Leuven, Belgium) was intro-
duced in all cases and followed by ultrasound passing
through the artery and the stenosis. After localizing the
stenosis, the length of the stenotic segment and diameter of
the artery were measured using B-mode. PSV ratio was
measured using colour mode (Fig. 1A and B). Balloon di-
ameters (Admiral Extreme PTA balloon, Medtronic; Med-
tronic Luc., Minneapolis, MN, USA. Mustang PTA balloon,
Boston Scientiﬁc, Boston Scientiﬁc international S.A.,
France), stent sizes and length (Scuba stent, Medtronic;
Omnilink Elite stent, Abbott Vascular, Abbot Vascular in-
ternational BVBA, Diegen, Belgium; Silver PTX drug eluting
stent, Cook Medical, Cook Medical Inc., Bloomington, IN,
USA) were chosen based on the Duplex measurement of
the stenotic segment. All PTA balloons were inﬂated
(Encore inﬂation device, Boston, MA, USA) and stents were
deployed under Duplex visualization (Fig. 2). After deﬂating
and withdrawing the balloon, leaving the guidewire in po-
sition, the PSV ratio was measured. Procedural success was
achieved if in B mode no stenosis was visible and the PSV
ratio was reduced below 50% of the original PSV. Duplex
examination of the infrapopliteal arterial segment was
performed in all cases searching for distal embolization.
Following removal of the endovascular material, manual
pressure was performed and a compression bandage was
placed on the puncture site.
Figure 2. Stent in the common iliac artery as depicted by ultra-
sound in B-mode.
Table 1. Patient characteristics and risk factors.
Characteristics N (%) patients
Male 25 (71)
Renal insufﬁciency 21 (68)
Contrast allergy 10 (32)
Age (years) 60 (44e84)a
BMI 25.3 (15.4e35.3)a
Risk factors
Diabetes mellitus 6 (19)
Smoking 23 (72)
Familiar vascular disease 15 (48)
Hypercholesterolemy 17 (55)
Heart failure 5 (16)
Hypertension 17 (55)
a Continuous variables are represented as mean with range.
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video (Video 1).
Supplementary video related to this article can be found
online at http://dx.doi.org/10.1016/j.ejvs.2013.08.011.
The following is the Supplementary video related to this
article:Video 1Compilation of the entire DuPTA procedure.Figure 3. Peak systolic velocity (PSV) pre- and post-DuPTA.Follow-up and evaluation
Patients were seen at the outpatient clinic 2 weeks after the
procedure. Patients underwent control arterial duplex, PSV
measurement, and ABIs. Procedural success was deﬁned as
crossing the lesion with a guidewire and dilating or stenting
the lesion. Clinical success was deﬁned as 50% reduction in
PSV or subjectively without complaints 2 weeks post
procedure.
This study was performed in accordance with local rules
of the medical ethics committee.
RESULTS
Average age of the patients ranged from 44 to 84 years
(mean 60 years). Body mass index (BMI) of the patients
ranged from 15.4 to 35.3 kg/m2 (mean 25.3). Stenotic le-
sions varied from 50% to 100% (mean 77.7%). Ten patients
with known contrast allergy were treated, all other patients
had impaired renal function (eGFR <60 ml/min/1.73 m2).
External iliac artery (EIA) was treated in 11 patients, all
other lesions were located in the common iliac artery (CIA)
stenosis (N ¼ 20). A total of 14 stents were placed (45%).
Concomitant risk factors included hypertension (55%),
diabetes mellitus (19%), congestive heart failure (16%),
smoking (72%), hypercholesterolemy (55%), and familiar
vascular disease (48%). (Confounding factors are shown in
Table 1.) All patients received statin and antiplatelet
therapy.
A total of 33 (94%) lesions were successfully treated.
Procedural success of TASCII-A-B lesions was 100%. In the
TASCII-B group, one occlusion was successfully recanalized.
Two TASCII-C lesions were treated. Both lesions could not
be recanalized.
The ﬁrst patient with a TASCII-C lesion was subsequently
treated successfully with conventional angiography withcontrast. The second patient was treated surgically because
of a known severe allergy for contrast. Treatment consisted
of a femoro-femoral crossover bypass with an 8 mm Braun
(Braun Melsungen, Berlin Germany) silver-coated pros-
thesis. Postoperative follow-up was uneventful.
Mean PSV prior to treatment was 440 mm/s, mean PSV
post procedure was 160 mm/s. An average reduction of
63% (Fig. 3). Mean PSV 2 weeks following DuPTA was
179 mm/s, showing a reduction of 60%. Mean preoperative
ABI was 0.72 and improved to 0.88 postoperatively.
Procedure time included a minimum of 10 minutes of
pressure. Mean procedure duration was 54 minutes,
ranging from 26 to 124 minutes. A total of 15 (43%,15/35)
stents were placed.
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During one procedure (right CIA), a stent was dislocated from
the mounted balloon during retraction. The lesion was suc-
cessfully crossedwith a 9mmstent. Howeverwhen positioning
the stent, theballoonmounted stent had to be retracted,which
was not inﬂated at that point. The stent dislodged from its
balloonduring retraction.Thiswasmost probably causedby the
high-grade stenosis (90%). This unfortunate mishap is a well
acknowledged complication, also seen in conventional PTA.The
stent was positioned proximal from the lesion in the proximal
common iliac artery, leaving no haemodynamic ﬂow limitation.DISCUSSION
Advancing Doppler-ultrasound technology, with high-
resolution colour Duplex has provided a safe and reliable
method for diagnosing peripheral artery disease. Currently all
reports describing Duplex-guided angioplasty involve infra-
inguinal arterial stenosis and show good results.1e8 These
studies show the feasibility of DuPTA in the femoro-popliteal
segment. To the best of our knowledge there is one report of
two patients that describes PTA of iliac arteries using duplex
guidance.9 As a consequence of the anatomical location,
treatment of signiﬁcant stenosis in iliac arteries using DuPTA
is more challenging in comparison with infra-inguinal limb
lesions. Other challenges include bowel gas and the patient’s
habitus. The goal of this feasibility study was to evaluate the
safety and efﬁcacy of DuPTA in the iliac arteries.
In DuPTA all procedural handlings are performed under
direct ultrasound guidance, puncture of the CFA is per-
formed avoiding atherosclerotic lesions. Conventional PTA
techniques are used during this novel method.
A major technical advantage of ultrasound is that di-
ameters and length of the stenotic lesion can be measured.
One must appreciate that conventional digital substraction
angiography (DSA) provides images of the intraluminal
diameter of a stenotic lesion. True vessel diameter can be
measured by ultrasonography, as opposed to DSA. Subse-
quently, more detailed attention can be given to sizing of
balloons and stents. Duplex renders direct and real time
reliable measurements of the stenotic lesions. After balloon
dilation it is therefore possible to directly measure the
improvement in PSVs, giving trustworthy information con-
cerning elastic recoil. Duplex can also be used to provide
reliable information of the haemodynamic signiﬁcance of
dissections. Angiography is not able to provide reliable
measurements to determine whether a dissection is hae-
modynamically signiﬁcant. Doppler ultrasound can predict
an unsuccessful procedure in 14% of cases despite earlier
satisfactory initial completion angiography.12 Completion
angiography is only accurate in 76%, signalling the need for
further dilatation to optimize the luminal diameter.8 Studies
reveal that angiography fails to identify haemodynamically
abnormal segments in nearly 30% of patients who had
multilevel disease compared with Duplex.13
Our anticipated problem of the visualization of the iliac ar-
teries in obesepatients appearedunjust. Patientswith aBMI as
high as 35.3 were able to be treated. The use of spinalanaesthesia relaxes the abdominal muscles, leading to optimal
visualization of the iliac arteries. Bowel gas is the most com-
mon cause of failing Duplex imaging in the iliac arteries.8 A
possible solution may be dietary advice in order to reduce
bowel gas formation. In our study, all patients were starved
overnight, potentially contributing to the effect of optimal
visualization and reaching 100% visibility in this study. Visuali-
zationspre-operatively andon thedayof the interventionwere
performed in order to assure 100% visibility.
In one patient we encountered dislodgement of the stent.
Visibility in this patient was not an issue. The authors believe
that the root of the problem was overadvancement of the
undeployed stent. Dislodgement occurred during retraction.
This technical problem can be avoided by crossing the lesion
with a sheet, then positioning the stent precisely where the
lesion is.The sheath is retractedwithoutmoving thepositioned
stent and subsequently the stent is deployed.
In visualization of TASCII-C lesions it is possible to clearly
visualize the subintimal positioned guidewire. We declined
from performing difﬁcult and strenuous subintimal crossing
of TASCII-C lesions at this point. One TASCII-B occlusion was
crossed with success.
The authors are convinced that in the future TASCII-C
lesions can be tackled. However, currently we are still in
the learning curve of this novel method.
In patients with an allergy for intravenous contrast agents,
DuPTA is a feasible and safe alternative when requiring an-
gioplasty. Mild allergic reactions are seen often, appearing in
5e8% of the patients receiving intravenous contrast. In 1%
of patients moderate reactions occur, such as nausea and
vomiting. Serious anaphylactic reactions present in 0.1%,
with one fatal reaction in every 75,000 patients.14
This study was set up as a feasibility study. To maximize
patient safety we decided to perform all procedures under
the most controlled conditions, that is in the operation
theatre under general or spinal anaesthesia. An additional
advantage is that maximum muscle relaxation would
improve visibility of the iliac vessels. However, all patients
met exclusion criteria, Duplex visibility. We conclude that
this advantage of muscle relaxation is of slight beneﬁt for
visibility of the iliac arteries. Currently we are exploring the
possibility of performing Duplex-guided PTA under local
anaesthesia in a randomized control trial comparing con-
ventional PTA with DuPTA.Conclusion
Duplex-guided balloon angioplasty and stenting is a safe and
effective technique treating patients with signiﬁcant iliac ar-
tery stenosis. Although we appreciate that DuPTA will not
replace conventional PTA, this newmethodmay be superior in
selected patients. Currently a prospective study in our clinic
has been started comparing DuPTA with conventional PTA.
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